IgG4-related diseases: State of the art on clinical practice guidelines

Luca Iaccarino, Rosaria Talarico, Carlo Alberto Scirè, Zahir Amoura, Gerd Burmester, Andrea Doria, Karim Faiz, Charissa Frank, Eric Hachulla, Miguel Hie, David Launay, Carlomaurizio Montecucco, Sara Monti, Luc Mouthon, Angela Tincani, Paola Toniati, Pieter Martin Van Hagen, Ronald F. Van Vollenhoven, Stefano Bombardieri, Ulf Mueller-LadnerMatthias Schneider, Vanessa Smith, Maurizio Cutolo, Marta Mosca, Tobias Alexander

Research output: Contribution to journalReview article

Abstract

Immunoglobulin G4-related diseases (IgG4-RD) are a group of chronic relapsing-remitting inflammatory conditions, characterised by tissue infiltration with lymphocytes and IgG4-secreting plasma cells, fibrosis and a usually favourable response to steroids. In this narrative review, we summarise the results of a systematic literature research, which was performed as part of the European Reference Network ReCONNET, aimed at evaluating existing clinical practice guidelines (CPGs) and recommendations in IgG4-RD. From 167 publications initially obtained from a systematic literature search, only one was identified as a systematic multispecialist, evidence-based, consensus guidance statement on diagnosis and treatment of IgG4-RD, which may be recommended for use as CPG in IgG4-RD. With the recognition of a limited evidence based in this increasingly recognised disease, the group discussion has identified the following unmet needs: lack of shared classification criteria, absence of formal guidelines on diagnosis, no evidence-based therapeutic recommendations and lack of activity and damage indices. Areas of unmet needs include the difficulties in diagnosis, management and monitoring and the scarcity of expert centres.

Original languageEnglish
Article numbere000787
JournalRMD Open
Volume4
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Practice Guidelines
Immunoglobulin G
Immunoglobulins
Plasma Cells
Publications
Fibrosis
Steroids
Guidelines
Lymphocytes
Research
Therapeutics

Keywords

  • clinical practice guidelines
  • ERN reconnet
  • european reference networks
  • IgG4-related diseases
  • unmet needs

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this

Iaccarino, L., Talarico, R., Scirè, C. A., Amoura, Z., Burmester, G., Doria, A., ... Alexander, T. (2019). IgG4-related diseases: State of the art on clinical practice guidelines. RMD Open, 4, [e000787]. https://doi.org/10.1136/rmdopen-2018-000787

IgG4-related diseases : State of the art on clinical practice guidelines. / Iaccarino, Luca; Talarico, Rosaria; Scirè, Carlo Alberto; Amoura, Zahir; Burmester, Gerd; Doria, Andrea; Faiz, Karim; Frank, Charissa; Hachulla, Eric; Hie, Miguel; Launay, David; Montecucco, Carlomaurizio; Monti, Sara; Mouthon, Luc; Tincani, Angela; Toniati, Paola; Van Hagen, Pieter Martin; Van Vollenhoven, Ronald F.; Bombardieri, Stefano; Mueller-Ladner, Ulf; Schneider, Matthias; Smith, Vanessa; Cutolo, Maurizio; Mosca, Marta; Alexander, Tobias.

In: RMD Open, Vol. 4, e000787, 01.01.2019.

Research output: Contribution to journalReview article

Iaccarino, L, Talarico, R, Scirè, CA, Amoura, Z, Burmester, G, Doria, A, Faiz, K, Frank, C, Hachulla, E, Hie, M, Launay, D, Montecucco, C, Monti, S, Mouthon, L, Tincani, A, Toniati, P, Van Hagen, PM, Van Vollenhoven, RF, Bombardieri, S, Mueller-Ladner, U, Schneider, M, Smith, V, Cutolo, M, Mosca, M & Alexander, T 2019, 'IgG4-related diseases: State of the art on clinical practice guidelines', RMD Open, vol. 4, e000787. https://doi.org/10.1136/rmdopen-2018-000787
Iaccarino L, Talarico R, Scirè CA, Amoura Z, Burmester G, Doria A et al. IgG4-related diseases: State of the art on clinical practice guidelines. RMD Open. 2019 Jan 1;4. e000787. https://doi.org/10.1136/rmdopen-2018-000787
Iaccarino, Luca ; Talarico, Rosaria ; Scirè, Carlo Alberto ; Amoura, Zahir ; Burmester, Gerd ; Doria, Andrea ; Faiz, Karim ; Frank, Charissa ; Hachulla, Eric ; Hie, Miguel ; Launay, David ; Montecucco, Carlomaurizio ; Monti, Sara ; Mouthon, Luc ; Tincani, Angela ; Toniati, Paola ; Van Hagen, Pieter Martin ; Van Vollenhoven, Ronald F. ; Bombardieri, Stefano ; Mueller-Ladner, Ulf ; Schneider, Matthias ; Smith, Vanessa ; Cutolo, Maurizio ; Mosca, Marta ; Alexander, Tobias. / IgG4-related diseases : State of the art on clinical practice guidelines. In: RMD Open. 2019 ; Vol. 4.
@article{4af1fb757cbb44cdbda5d5a338d7ac9c,
title = "IgG4-related diseases: State of the art on clinical practice guidelines",
abstract = "Immunoglobulin G4-related diseases (IgG4-RD) are a group of chronic relapsing-remitting inflammatory conditions, characterised by tissue infiltration with lymphocytes and IgG4-secreting plasma cells, fibrosis and a usually favourable response to steroids. In this narrative review, we summarise the results of a systematic literature research, which was performed as part of the European Reference Network ReCONNET, aimed at evaluating existing clinical practice guidelines (CPGs) and recommendations in IgG4-RD. From 167 publications initially obtained from a systematic literature search, only one was identified as a systematic multispecialist, evidence-based, consensus guidance statement on diagnosis and treatment of IgG4-RD, which may be recommended for use as CPG in IgG4-RD. With the recognition of a limited evidence based in this increasingly recognised disease, the group discussion has identified the following unmet needs: lack of shared classification criteria, absence of formal guidelines on diagnosis, no evidence-based therapeutic recommendations and lack of activity and damage indices. Areas of unmet needs include the difficulties in diagnosis, management and monitoring and the scarcity of expert centres.",
keywords = "clinical practice guidelines, ERN reconnet, european reference networks, IgG4-related diseases, unmet needs",
author = "Luca Iaccarino and Rosaria Talarico and Scir{\`e}, {Carlo Alberto} and Zahir Amoura and Gerd Burmester and Andrea Doria and Karim Faiz and Charissa Frank and Eric Hachulla and Miguel Hie and David Launay and Carlomaurizio Montecucco and Sara Monti and Luc Mouthon and Angela Tincani and Paola Toniati and {Van Hagen}, {Pieter Martin} and {Van Vollenhoven}, {Ronald F.} and Stefano Bombardieri and Ulf Mueller-Ladner and Matthias Schneider and Vanessa Smith and Maurizio Cutolo and Marta Mosca and Tobias Alexander",
year = "2019",
month = "1",
day = "1",
doi = "10.1136/rmdopen-2018-000787",
language = "English",
volume = "4",
journal = "RMD Open",
issn = "2056-5933",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - IgG4-related diseases

T2 - State of the art on clinical practice guidelines

AU - Iaccarino, Luca

AU - Talarico, Rosaria

AU - Scirè, Carlo Alberto

AU - Amoura, Zahir

AU - Burmester, Gerd

AU - Doria, Andrea

AU - Faiz, Karim

AU - Frank, Charissa

AU - Hachulla, Eric

AU - Hie, Miguel

AU - Launay, David

AU - Montecucco, Carlomaurizio

AU - Monti, Sara

AU - Mouthon, Luc

AU - Tincani, Angela

AU - Toniati, Paola

AU - Van Hagen, Pieter Martin

AU - Van Vollenhoven, Ronald F.

AU - Bombardieri, Stefano

AU - Mueller-Ladner, Ulf

AU - Schneider, Matthias

AU - Smith, Vanessa

AU - Cutolo, Maurizio

AU - Mosca, Marta

AU - Alexander, Tobias

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Immunoglobulin G4-related diseases (IgG4-RD) are a group of chronic relapsing-remitting inflammatory conditions, characterised by tissue infiltration with lymphocytes and IgG4-secreting plasma cells, fibrosis and a usually favourable response to steroids. In this narrative review, we summarise the results of a systematic literature research, which was performed as part of the European Reference Network ReCONNET, aimed at evaluating existing clinical practice guidelines (CPGs) and recommendations in IgG4-RD. From 167 publications initially obtained from a systematic literature search, only one was identified as a systematic multispecialist, evidence-based, consensus guidance statement on diagnosis and treatment of IgG4-RD, which may be recommended for use as CPG in IgG4-RD. With the recognition of a limited evidence based in this increasingly recognised disease, the group discussion has identified the following unmet needs: lack of shared classification criteria, absence of formal guidelines on diagnosis, no evidence-based therapeutic recommendations and lack of activity and damage indices. Areas of unmet needs include the difficulties in diagnosis, management and monitoring and the scarcity of expert centres.

AB - Immunoglobulin G4-related diseases (IgG4-RD) are a group of chronic relapsing-remitting inflammatory conditions, characterised by tissue infiltration with lymphocytes and IgG4-secreting plasma cells, fibrosis and a usually favourable response to steroids. In this narrative review, we summarise the results of a systematic literature research, which was performed as part of the European Reference Network ReCONNET, aimed at evaluating existing clinical practice guidelines (CPGs) and recommendations in IgG4-RD. From 167 publications initially obtained from a systematic literature search, only one was identified as a systematic multispecialist, evidence-based, consensus guidance statement on diagnosis and treatment of IgG4-RD, which may be recommended for use as CPG in IgG4-RD. With the recognition of a limited evidence based in this increasingly recognised disease, the group discussion has identified the following unmet needs: lack of shared classification criteria, absence of formal guidelines on diagnosis, no evidence-based therapeutic recommendations and lack of activity and damage indices. Areas of unmet needs include the difficulties in diagnosis, management and monitoring and the scarcity of expert centres.

KW - clinical practice guidelines

KW - ERN reconnet

KW - european reference networks

KW - IgG4-related diseases

KW - unmet needs

UR - http://www.scopus.com/inward/record.url?scp=85060282316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060282316&partnerID=8YFLogxK

U2 - 10.1136/rmdopen-2018-000787

DO - 10.1136/rmdopen-2018-000787

M3 - Review article

AN - SCOPUS:85060282316

VL - 4

JO - RMD Open

JF - RMD Open

SN - 2056-5933

M1 - e000787

ER -